The study aims to elucidate the mechanisms by which gut microbiota modulates immune regulation in ARDS, enhance the understanding of the disease's pathophysiology, and explore the feasibility of combining FMT with JAK/STAT pathway interventions, potentially offering novel therapeutic strategies for clinical management of ARDS. This evidence concerns the gene SOAT1 and acute respiratory distress syndrome.